⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30535283 | 0.79 | LMNA (0.82) | — | |
| SCHEMBL676142 | 0.79 | LMNA (0.82) | — | |
| SCHEMBL18937770 | 0.78 | CYP2A6 (0.56) | — | |
| Potassium SCHEMBL6776357 | 0.77 | LMNA (0.78) | — | |
| SCHEMBL12539198 | 0.75 | — | — | |
| SCHEMBL162478 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL8051614 | 0.75 | LMNA (0.56) | — | |
| SCHEMBL16114401 | 0.75 | LMNA (0.75) | — | |
| SCHEMBL4459718 | 0.75 | — | — | |
| SCHEMBL272062 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230113398-A1 | INEXPENSIVE METAL-FREE ORGANIC REDOX FLOW BATTERY (ORBAT) FOR GRID-SCALE STORAGE | UNIV SOUTHERN CALIFORNIA (US) | 2023-04-13 | — | — | US | disclosed |
| EP-3323812-B1 | ARYLALKYL-AND ARYLOXYALKYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS | PARION SCIENCES INC (US) | 2019-08-14 | — | — | EP | disclosed |
| US-9745272-B2 | Quinazoline-2,4(1 H,3H)-dione derivatives | HYDRA BIOSCIENCES, INC. (US) | 2017-08-29 | — | — | US | disclosed |
| EP-2475657-B1 | 5-ALKINYLTHIEN-2-YLCARBOXYLIC ACIDS AS INHIBITORS OF FLAVIVIRIDAE VIRUSES | GILEAD SCIENCES INC (US) | 2013-06-12 | — | — | EP | disclosed |
| WO-2010135360-A1 | ISOXAZOLINES AS INHIBITORS OF FATTY ACID AMIDE HYDROLASE | INFINITY PHARMACEUTICALS, INC. (US) | 2010-11-25 | — | — | WO | disclosed |